Laboratory Diagnosis of Haematological Malignancies 2018
Laboratory Diagnosis of Haematological Malignancies 2018
Organiser: Ricardo Morilla (The Royal Marsden Hospital) and Ulrika Johansson (Bristol Royal Infirmary)
For laboratory staff and clinicians in the fields of flow cytometry, cytogenetic and molecular biology looking to obtain more accurate and reliable results, this meeting will consist of a number of informative, educational talks full of information to take back to the workplace as well as an exhibition of leading companies in the field.
Unfortunately this meeting has been cancelled.
Should you have any questions, please email [email protected]
Programme
Organisers
Scientific Organisers
-
Mr Ricardo Morilla
Royal Marsden Hospital
Ricardo Morilla is a Clinical Scientist and the Head of Immunophenotyping. The laboratory is part of the Haemato-Oncology Section for the integrated study of leukaemia and lymphoma.
He runs a flow cytometry diagnostic service which is strongly involved in the practice and teaching of haemato-ocology diagnosis, including many applications into clinical diagnostics such as cell immunophenotyping, stem cell transplantation, PNH and minimal residual disease detection. Ricardo is a member of the MIG UK group which is a national group working on the multicolour immunophenotyping guidelines for the UK. He participates as a lecturer in the Royal Microscopical Society’s courses and meetings. He also organises an annual meeting on the Laboratory Diagnosis of Haemato-Oncology disorders. His main research interest is the multiparameter analysis of the leukaemic cells. He is enthusiastic to work in the RMS with other experts in the field to promote and disseminate flow cytometry knowledge and skills at many levels and to encourage national and international networking. -
Dr Ulrika Johansson
Bristol Royal Infirmary
Ulrika obtained her PhD from Imperial College, London, after which she worked as a Clinical Scientist with Marion Macey at Bart’s and The London. She moved to Bristol University Hospital in 2008, where she now runs the Haematology Flow Cytometry Lab.
Invited Speakers
-
Steve Couzens
University of Wales College of Medicine
Steve is the current head of the Immunophenotyping laboratory in the Department of Haematology at the University Hospital of Wales in Cardiff. Having started as a Biomedical Scientist, Steve undertook the STP Equivalence process in 2014 and is now registered as a Clinical Scientist with the HCPC. He passed the RCPath Part 2 examination in 2015. Steve is a member of a number of expert groups including the Multi-Colour Immunophenotyping Group (MIG) and organises the clinical module of the annual RMS International Flow Cytometry Course. -
Dr Emma Nicholson
Royal Marsden Hosptial
Dr Nicholson is a Consultant Haematologist at Royal Marsden Hosptial with a specialist interest in stem cell transplantation, acute leukaemia and teenage and young adult patients with haematological malignancies. She graduated from Glasgow University in 2002 and undertook her postgraduate haematology specialist training in Glasgow and London. She was awarded a PhD in 2013 from UCL and her research focused on the transduction of CD4+ T cells with class I restricted TCRs and improving avidity by co-transduction of CD3. She was appointed as a Consultant Haematologist at Royal Marsden Hospital in 2016. She is clinical lead for stem cell transplant clinical trials and for CAR-T therapies for haematological malignancies.
-
Prof Sylvie Freeman
University of Birmingham
Prof Sylvie Freeman is co-director of the Clinical Immunology Service at the Institute of Immunology and Immunotherapy, Birmingham University, leading Immunophenotyping for the diagnosis and monitoring of haematological malignancies. The service provides a unique interface between the University's substantial R&D expertise in immunohaematology and the clinical investigation and management of blood cancers and immunodeficiency in the NHS and for trials.Her research is focussed on predicting treatment resistance in acute myeloid leukemia and myelodysplasia principally by monitoring residual disease (MRD). She leads flow cytometric MRD detection for the NCRI acute myeloid leukemia trials and is part of the TMG of these trials. Sylvie is a member of the UK NCRI AML Working Party and European LeukemiaNet AMLMRD Working Group
-
Katy Sanchez
Viapath
Katy has 18 years extensive experience in specialist diagnostic haematology in 2 of London's leading trusts. Her career started at Guy’s & St Thomas’ Hospitals where she achieved BSc(hons), MSc degrees and HCPC registration and where she developed a keen interest in haemato-oncology whilst working with the late Professor David Grimwade developing a clinical MRD assay for APML patients. In 2016, her expertise in molecular techniques and flow cytometry lead her to her current position as operational lead and deputy head in the Viapath Analytics Immunophenotyping Laboratory within the Haematological Malignancy Diagnostic Centre at King College Hospital.
Venue Details and Further Information
The meeting will be held at:
1 America Square, 1
7 Crosswall
London
EC3N 2LB
The meeting is likely to being at 0930 and finish at 1700.
Registration will include entrance to the meeting, refreshments and a buffet lunch.
Sponsorship
-
BD Biosciences
BD Biosciences is a world leader in bringing innovative diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production and disease management. The BD Biosciences segment is focused on continually advancing the science and applications associated with cellular analysis.
Find out more about BD Biosciences
www.bdbiosciences.com
If you are interested in exhibiting at or sponsoring this meeting, please contact Karina Lang.